Detalhe da pesquisa
1.
Survival Analysis of Newly Diagnosed Multiple Myeloma Patients after Frontline Autologous Stem Cell Transplantation in a Real-Life Setting.
Acta Medica (Hradec Kralove)
; 66(3): 117-121, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38511422
2.
Epidemiology and risk factors for the development of infectious complications in newly diagnosed multiple myeloma: a multicenter prospective cohort study in Uruguay.
Hematol Transfus Cell Ther
; 2023 Oct 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38307822
3.
Primary plasma cell leukemia in Latin America: demographic, clinical, and prognostic characteristics. A study of GELAMM group.
Leuk Lymphoma
; 64(4): 816-821, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36695519
4.
Patients Age 40 Years and Younger With Multiple Myeloma Have the Same Prognosis as Older Patients: An Analysis of Real-World Patients' Evidence From Latin America.
JCO Glob Oncol
; 9: e2300182, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-38060975
5.
Epidemiology and Risk Factors for the Development of Infectious Complications in Newly Diagnosed Multiple Myeloma: A Multicenter Prospective Cohort Study in Latin America.
JCO Glob Oncol
; 8: e2200068, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35867949
6.
Treatment and Survival Outcomes of Waldenstrom Macroglobulinemia in Latin American Patients: A Multinational Retrospective Cohort Study.
JCO Glob Oncol
; 8: e2100380, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35939775
7.
Young age and autologous stem cell transplantation are associated with improved survival in newly diagnosed multiple myeloma.
Hematol Transfus Cell Ther
; 43(3): 295-302, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-32912838
8.
Comparative survival analysis using the International Stratification Score (ISS) in newly-diagnosed multiple myeloma in the Uruguayan population.
Med Pharm Rep
; 94(1): 48-52, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33629048
9.
Different outcomes for transplant-eligible newly diagnosed multiple myeloma patients in Latin America according to the public versus private management: a GELAMM study.
Leuk Lymphoma
; 61(13): 3112-3119, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32844699
10.
Consenso del Grupo de Estudio Latinoamericano de Mieloma Múltiple (MM) GELAMM para el manejo del MM en estado de pandemia SARS-CoV-2 / COVID- 19 / Consensus of the Latin American Study Group on Multiple Myeloma (MM) GELAMM for the management of MM in a state of Pandemic SARS-CoV-2 / COVID-19
Rev. colomb. cancerol
; 24(supl.1): 227-240, oct.-dic. 2020. tab, graf
Artigo
em Espanhol
| LILACS | ID: biblio-1251510
11.
Efectividad del tratamiento con bortezomib en pacientes con mieloma múltiple en el Hospital de Clínicas en el período 2009-2016. Montevideo, Uruguay / Effectiveness of bortezomib treatment in patients with multiple myeloma at the Clínicas Hospital between 2009 and 2016. Montevideo, Uruguay
Rev. méd. Urug
; 34(4): 209-216, dic. 2018.
Artigo
em Espanhol
| LILACS | ID: biblio-968106
12.
Efectividad del tratamiento con bortezomib en pacientes con mieloma múltiple en el Hospital de Clínicas en el período 2009-2016. Montevideo, Uruguay / Effectiveness of bortezomib treatment in patients with multiple myeloma in the Hospital de Clínicas in the period 2009-2016. Montevideo, Uruguay
Rev. méd. Urug
; 34(4): 209-216, 2018. ilus
Artigo
em Espanhol
| URUCAN | ID: bcc-5286
13.
Real-world data on multiple myeloma: a prospective National Registry in Uruguay
Blood
; 126: [2 p.], 2015.
Artigo
em Inglês
| URUCAN | ID: bcc-5091